the aid library

LIST OPTIONS

Filter

635

Procedimiento de actuación frente a casos de infección por el nuevo coronavirus (SARS-CoV-2)

Ministerio de sanidad - España DIRECCIÓN GENERAL DE SALUD PÚBLICA, CALIDAD E INNOVACIÓN (2020) C1

Este documento ha sido revisado y aprobado por la Ponencia de Alertas y Planes de Preparación y Respuesta. Este protocolo está en revisión permanente en función de la evolución y nueva información que se disponga de la infección por el nuevo coronavirus (SARS-CoV-2 ) .

Situational Analysis Report on Antimicrobial Resistance in Pakistan

The Center for Disease Dynamics, Economics & Policy CDDEP (2016) C2

Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet... more

Download (114)

View PDF (161)

Preparing for large-scale community transmission of COVID-19

World Health Organization WHO (2020) C_WHO

This document is a guide for national authorities who are responsible for managing public health responses to COVID-19

Download (199)

View PDF (144)

Exames laboratoriais para a doença causada pelo novo coronavírus (COVID-19) de casos suspeitos em humanos

Pan American Health Organization PAHO, World Health Organization WHO (2020) C_WHO

Este documento apresenta uma orientação provisória aos laboratórios e diferentes atores envolvidos na realização de exames laboratoriais para o vírus COVID-19. Ele baseia-se parcialmente na orientação provisória para os exames laboratoriais do coronavírus da Síndrome Respiratória do Ori... more

Download (131)

View PDF (177)

Обеспечение достаточных запасов безопасной крови и сбор плазмы реконвалесцентов в условиях пандемии COVID-19

World Health Organization WHO (2021) C_WHO

: interim guidance, 17 February 2021 This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that... more

Download (251)

View PDF (161)

Environmental and Social Management Framework (Final Report) for the COVID-19 Emergency Preparedness and Response Project

Ministry pf Health and Sanitation Sierra Leone (2021) CC

COVID-19 Scientific and Public Health Policy Update – (6 July 2022)

African Union; Africa CDC Centres for Disease Control and Prevention (2022) C1

This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.

Download (308)

View PDF (778)

India: Guidelines on Airborne Infection Control in Healthcare and Other Settings

Directorate General of Health Services , Ministry of Health & Family Welfare, Government of India (2010) C1

Download (630)

View PDF (349)

An activist's guide to Tuberculosis Diagnostic Tools

Treatment Action Group (2017) C2

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (254)

View PDF (580)

Ebola virus disease in the Democratic Republic of the Congo – Operational readiness and preparedness in neighbouring countries

World Health Organization WHO (2018) C_WHO

Revised National Guidelines on Mpox

Wasif Malik, M.; et al. National Institute of Health, Pakistan (2024) CC

This document serves to provide interim guidance/ recommendations to carry out mpox surveillance activities mainly case investigation, contact tracing and isolation. For the development of this document WHO, UKHSA and CDC guidelines were referred to and adopted within the country context.

Download (1522)

View PDF (2944)

Dengue Guidelines For Diagnosis, Treatment, Prevention and Control
recommended

World Health Organization; TDR (2009) C_WHO

New edition

Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource-limited Settings

World Health Organization WHO (1999) C_WHO

These guidelines are designed for settings with limited resources to provide inexpensive and effective control strategies for prevention of TB transmission in health care workers (HCW).

WHO Strategic Action Plan for Ebola Outbreak Response

World Health Organization (2014)

Ebola Virus Disease Outbreak Response Plan in West Africa July to December 2014. Annex 1

Planned Response to the Ebola Virus Disease Epidemic in Guinea

Ministry of Health, Guinea (2014)

Ebola Virus Disease Outbreak Response Plan in West Africa. Annex 2

External Link

Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
recommended

Schieffelin, JS.; J.G. Shaffer; A. Goba, et al. (2014)

External Link

PPE Selection Matrix for Occupational Exposure to Ebola Virus

OSHA Occupational Safety and Health Administration (2014)

External Link

Framework Ebola Virus Disease

Robert-Koch-Institut (2015) CC2

The document is intended to facilitate the detection, evaluation and management of incident EVD cases in Germany. It primarily addresses public health service staff and health care workers in hospitals, outpatient clinics and emergency services in Germany. It is a work in progress, intended to evolv... more

Download (988)

View PDF (2288)

Ebola- local beliefs and behaviour change

Grant, C. HEART (2014)

What are the local beliefs and practices around illnesses and death, the transmission of disease and spirituality, which affect decision-making (around health-seeking behaviour, caring for relatives and nature of burials) and can inform effective behaviour change interventions for preventing Ebola i... more

Dengue Guidelines For Diagnosis, Treatment, Prevention and Control recommended

Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone recommended

Dengue Guidelines For Diagnosis, Treatment, Prevention and Control
recommended

Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone
recommended